Late-onset pulmonary arterial hypertension in association with graft-versus-host disease after allogeneic stem-cell transplantation

American Journal of Hematology

Volumn 80, Issue 1, 2005, Pages 38-42

  Grigg, Andrew ^a   Buchanan, Malcolm ^a   Whitford, Helen ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

GVHD; Pulmonary hypertension; Stem cell transplant

Indexed keywords

ACICLOVIR; BOSENTAN; BUSULFAN; CALCIUM CHANNEL BLOCKING AGENT; CARMUSTINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIURETIC AGENT; ESTROGEN; ETHINYLESTRADIOL; FUROSEMIDE; LEVONORGESTREL; METHOTREXATE; MYCOPHENOLIC ACID; NIFEDIPINE; ORAL CONTRACEPTIVE AGENT; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; TESTOSTERONE; TRANDOLAPRIL; WARFARIN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIHYPERTENSIVE THERAPY; ARTERY INTIMA PROLIFERATION; ARTICLE; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EDEMA; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; LUNG BLOOD VESSEL; ONSET AGE; OPEN LUNG BIOPSY; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION;

ADULT; FEMALE; GRAFT VS HOST DISEASE; HUMANS; HYPERTENSION, PULMONARY; LEUKEMIA, MYELOID, CHRONIC; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 24344477009     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20373     Document Type: Article

References (13)

1. Sakaida E, Nakaseko C, Harima A, et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 2003;102:4236-4242.
2. Freudenberger TD, Madtes DK, Curtis JR, et al. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood 2003;102:3822-3828.
3. Kaplan EB, Pietra GG, August CS. Interstitial pneumonitis, pulmonary fibrosis, and chronic graft-versus-host-disease. Bone Marrow Transplant 1992;9:71-75.
4. Vaksmann G, Nelken B, Deshildre A, et al. Pulmonary arterial occlusive disease following chemotherapy and bone marrow transplantation for leukaemia. Eur J Pediatr 2002;161:247-249.
5. Seguchi M, Hirabayashi N, Fujii, Y et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 2000;69:177-179.
6. Hackman RC, Madtes DK, Finn B. Pulmonary venoocclusive disease following bone marrow transplantation. Transplantation 1989;47:989-992.
7. Cool CD, Rai PR, Yeager ME, et al. Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med 2003;349:1113-1122.
8. Channick RN, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 2001;358:1119-1123.
9. Binet I, Wallnofer A, Weber C, et al. Renal haemodynamics and pharmacokinetics of bosentan with and without cyclosporine A. Kidney Int 2000;57:224-231.
10. Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulmonary disease. Evaluation and management. Chest 1991;99:715-723.
11. Luppi M, Barozzi P, Schulz TF, et al. Nonmalignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation. Blood 2000;96:2355-2357.
12. Daly AS, Xenocostas A. Lipton JH. Transplantation-associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant 2002;30:709-715.
13. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533-1544.